Molecular Diagnostics Reagent Market
Molecular Diagnostics Reagent Market Study by Sample Preparation Kits, PCR Assay Kits, In situ Hybridization Kits, Microarray Kits, and Sequencing Kits from 2024 to 2034
Analysis of Molecular Diagnostics Reagent Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Molecular Diagnostics Reagent Market Outlook (2024 to 2034)
The molecular diagnostics reagent market size is anticipated to accelerate at a 6.6% CAGR from 2024 to 2034. The global demand for molecular diagnostic reagents is expected to attain US$ 20,009.6 million by 2034, from an estimated US$ 10,584.3 million market size in 2024.
Since infectious diseases and other cancer variations are becoming prevalent, there has been a noticeable increase in demand for molecular diagnostics reagents, fueling the market. Increasing biomarker discovery and rising awareness and acceptance of tailored medication dosages are predicted to support the market.
Contributing Elements to the Upward Trajectory of the Molecular Diagnostics Reagent Market
One major factor boosting the market is the increase in cases of infectious diseases. To effectively manage and control the spread of diseases, molecular diagnostics is essential for quickly and precisely detecting infections.
The industry is expanding due to government programs that encourage financial support for molecular diagnostics research and development. Public health initiatives and capital expenditures influence the healthcare sector's demand for molecular diagnostics reagents.
An increase in the prevalence of chronic diseases is linked to the demographic change towards an aging population. The need for the early identification and monitoring of numerous diseases in the elderly population is fueling the market demand.
The rising trend towards precision medicine and personalized treatments depending on a patient's genetic composition is increasing the sales of molecular diagnostics reagents, as they are essential for locating particular biomarkers for focused therapies.
| Report Attributes | Details |
|---|---|
| Estimated Market Value (2024E) | US$ 10,584.3 million |
| Forecasted Market Value (2034F) | US$ 20,009.6 million |
| Global Market Growth Rate (2024 to 2034) | 6.6% |
| Sequencing Kit Segment Growth Rate (2024 to 2034) | 7.4% |
| Pathogen Detection Segment Growth Rate (2024 to 2034) | 6.7% |
| North America Market Share (2024) | 6.4% |
| East Asia Market Share (2024) | 7.0% |
| Key Companies Profiled |
|
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Which Factors are Constraining the Molecular Diagnostics Reagent Market?
“Absence of Defined Methods and Guidelines and Ethical Issues”
Molecular diagnostic tests and related reagents prove costly compared to conventional diagnostic techniques. The high cost inhibits molecular diagnostic testing adoption, particularly in healthcare settings with limited resources and financial constraints. The absence of defined methods and guidelines hampers the adoption of molecular diagnostic testing. Test reliability and findings decrease due to inconsistent procedures used in different laboratories and platforms.
When using molecular diagnostics, sensitive genetic data must be gathered and analyzed. Healthcare practitioners and patients can be reluctant due to worries about data security, privacy, and ethical issues. The technologies used for molecular diagnostics are developing, and their complexity makes their general adoption difficult. One potential barrier to the accessibility and adoption of molecular biology techniques is a lack of specific training and competence in the workforce.
Country-wise Analysis
The molecular diagnostics reagent market in North America is set to develop at a CAGR of 6.4% through 2034. The rising demand for molecular diagnostics reagents in major countries, especially the United States and Canada, is the primary catalyst behind the spike. The United States tops the molecular diagnostics technology industry with an estimated share of 79.2%.
The market in East Asia is expected to advance at a 7.0% CAGR through 2034. Japan has emerged as the dominant force, with a 53.7% market share in East Asia.
What is Driving the North America Molecular Diagnostics Reagent Market?
“Adoption of Advanced Diagnostic Technologies Shaping the Market”
The United States is the leading market with a focus on innovation and reagent adoption for molecular diagnostics. The rising focus on substantial investment in research and development and increasing emphasis on tailored healthcare treatments are propelling market growth. In 2024, the United States is poised to hold a 79.8% market share.
| Attributes | Details |
|---|---|
| United States Market CAGR | 6.3% |
| United States Market Size (2024) | US$ 3000 million |
| Canada Market CAGR | 7.0% |
| Canada Market Size (2024) | US$ 498 million |
In line with global health trends, Canada's demand for molecular diagnostic reagents is rising due to the emphasis on environmentally friendly and sustainable healthcare solutions. The rising incidence of infectious diseases in Canada is creating a greater need for early diagnosis, which in turn is pushing up the price of molecular diagnostics reagents. Canada is going to capture a 13.3% market share in 2024.
What is Fueling Growth in the Asia Pacific Molecular Diagnostics Reagent Market?
“Government Initiatives Promoting Precision Medicine and Adoption of Molecular Diagnostics Reagents”
Japan's dedication to personalized healthcare aligns with the demand for highly specialized and customized molecular diagnostics reagents driven by the country's predominance of precision medicine efforts. A distinct market dynamic for molecular diagnostics reagents, with an emphasis on treating age-related diseases and ailments, is created by Japan's aging population. Japan is expected to garner a 52% market share in 2024.
| Attributes | Details |
|---|---|
| Japan Market CAGR | 7.3% |
| Japan Market Size (2024) | US$ 913 million |
| China Market CAGR | 6.03% |
| China Market Size (2024) | US$ 524 million |
China's development and adoption of novel molecular diagnostic reagents are accelerated by incorporating artificial intelligence and modern technologies into healthcare systems. The demand for molecular diagnostics reagents is stimulated by China's growing emphasis on preventive healthcare, which aligns with a broader trend toward proactive illness management. In 2024, China is projected to hold a 29.9% market share.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Category-wise Outlook
Based on the product type, the PCR assay kits segment is estimated to hold a 26.7% of the global molecular diagnostics reagent market share. Simultaneously, the sample preparation kits segment is anticipated to secure a noteworthy 22% share, contributing significantly to the market. Based on the end user, the therapeutic monitoring segment marks its dominance, with a share of 32.9%.
Why is Demand for PCR Assay Kits Rising in the Molecular Diagnostics Reagent Market?
“Continuous Advancements in PCR Technology to Spur Sales of PCR Assay Kits”
| PCR Assay Kits | Details |
|---|---|
| Market Size (2024) | US$ 2,946.6 million |
| Market Share (2024) | 27.8% |
Innovation is sustained by ongoing improvements in PCR technology, which keeps PCR assay kits at the top of the molecular diagnostics reagent industry. The popularity of PCR assays in detecting and quantifying target nucleic acids is attributed to their high sensitivity and specificity.
PCR technique is the method of choice for routine diagnostic applications due to its cost-effectiveness and quick response time. From 2024 to 2034, the PCR assay kit segment is expected to develop at a CAGR of 6.1%.
What Makes the Therapeutic Monitoring Segment the Frontrunner in the Market?
“Therapeutic Monitoring Plays a Pivotal Role in Tailoring Treatments”
| Therapeutic Monitoring | Details |
|---|---|
| Market Size (2024) | US$ 3,572.2 million |
| Market Share (2024) | 33.7% |
Its critical influence on physicians' choices and advancing efficient and customized patient care strengthens the segment's leadership. Therapeutic monitoring lowers the need for pointless therapies and their related expenses, which helps the category command the molecular diagnostics reagent market.
The therapeutic monitoring segment is leading because it helps in treatment customization, reducing adverse effects, and improving patient outcomes. The segment is expected to evolve at a CAGR of 6.3% from 2024 to 2034.
Competition Analysis
Key players in the molecular diagnostics reagent market include Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies, Inc., Qiagen N.V., Illumina, Inc., DiaSorin S.p.A, Hologic Inc., and Others.
Key molecular diagnostics reagent vendors are engaged in fierce competition as they vie for higher profits in the market. To improve their market position, major market players concentrate on strategic activities such as collaborations, mergers, acquisitions, and product innovations.
Technological breakthroughs, global presence, and significant research and development activities are crucial factors impacting the competitive landscape. Molecular diagnostics reagent manufacturers collaborate with academic institutions and healthcare organizations to improve their product offerings and broaden their market penetration.
Maintaining competitiveness depends on adhering to quality standards and following regulations. Due to the dynamic nature of the market, molecular diagnostics reagent suppliers are constantly competing for market share and long-term success. This needs constant adaptation to changing trends.
Notable Advancements
- In September 2021, F. HOFFMAN LA-ROCHE LTD. announced the acquisition of TIB Molbiol (Germany) to add a wide variety of assays for infectious diseases to its line of PCR tests.
- For in-vitro diagnosis, Bio-Rad Laboratories, Inc. introduced the Reliance SARS-CoV-2/FluA/FluB RT-PCR Kit in July 2021. Assay reagents and standard and negative molecular controls are included in the kit.
- To access state-of-the-art molecular diagnostics technology, Roche announced in March 2021 that it would merge and purchase GenMark Diagnostics. This collaboration makes it possible to screen for a wide variety of infections using a single patient sample. Through this partnership, the company was able to increase both its geographic reach and business growth at a faster rate.
- Biotheranostics Inc. (United States) was acquired by Hologic, Inc. (United States) in January 2021 to expand its offerings in molecular diagnostics.
- In December 2020, GeneIQ in Dallas changed its focus to address the COVID-19 pandemic, and this move has contributed to the company's notable expansion.
- In March 2020, Abbott introduced a molecular point-of-care test that can diagnose the new coronavirus in five minutes. This was the second test created by the company and was approved by the FDA for use in an emergency to identify COVID-19.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Segmentation of Molecular Diagnostics Reagent Market Research
-
By Product Type:
- Sample Preparation Kits
- PCR Assay Kits
- In situ Hybridization Kits
- Microarray Kit
- Sequencing Kit
-
By Application:
- Pathogen Detection
- Biomarker Screening
- Therapeutic Monitoring
- Others
-
By End User:
- Hospitals
- Laboratories
- Research Institutes
- Biopharmaceutical Companies
- Others
-
By Region:
- North America
- East Asia
- East Asia
- South Asia and Pacific
- Western Europe
- Eastern Europe
- Middle East and Africa
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2019-2023 and Forecast, 2024-2034 4.1. Historical Market Size Value (US$ Mn) & Volume (Unit) Analysis, 2019-2023 4.2. Current and Future Market Size Value (US$ Mn) & Volume (Unit) Projections, 2024-2034 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2019-2023 and Forecast 2024-2034, By Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Mn) & Volume (Unit) Analysis By Type, 2019-2023 5.3. Current and Future Market Size Value (US$ Mn) & Volume (Unit) Analysis and Forecast By Type, 2024-2034 5.3.1. Sample Preparation Kits 5.3.2. PCR Assay Kits 5.3.3. In Situ Hybridization Kits 5.3.4. Microarray Kit 5.3.5. Sequencing Kit 5.4. Y-o-Y Growth Trend Analysis By Type, 2019-2023 5.5. Absolute $ Opportunity Analysis By Type, 2024-2034 6. Global Market Analysis 2019-2023 and Forecast 2024-2034, By Application 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Mn) & Volume (Unit) Analysis By Application, 2019-2023 6.3. Current and Future Market Size Value (US$ Mn) & Volume (Unit) Analysis and Forecast By Application, 2024-2034 6.3.1. Hospitals 6.3.2. Laboratories 6.3.3. Research Institutes 6.3.4. Biopharmaceutical Companies 6.3.5. Others 6.4. Y-o-Y Growth Trend Analysis By Application, 2019-2023 6.5. Absolute $ Opportunity Analysis By Application, 2024-2034 7. Global Market Analysis 2019-2023 and Forecast 2024-2034, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Mn) & Volume (Unit) Analysis By Region, 2019-2023 7.3. Current Market Size Value (US$ Mn) & Volume (Unit) Analysis and Forecast By Region, 2024-2034 7.3.1. North America 7.3.2. Latin America 7.3.3. Western Europe 7.3.4. Eastern Europe 7.3.5. South Asia and Pacific 7.3.6. East Asia 7.3.7. Middle East and Africa 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis 2019-2023 and Forecast 2024-2034, By Country 8.1. Historical Market Size Value (US$ Mn) & Volume (Unit) Trend Analysis By Market Taxonomy, 2019-2023 8.2. Market Size Value (US$ Mn) & Volume (Unit) Forecast By Market Taxonomy, 2024-2034 8.2.1. By Country 8.2.1.1. U.S. 8.2.1.2. Canada 8.2.2. By Type 8.2.3. By Application 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Type 8.3.3. By Application 8.4. Key Takeaways 9. Latin America Market Analysis 2019-2023 and Forecast 2024-2034, By Country 9.1. Historical Market Size Value (US$ Mn) & Volume (Unit) Trend Analysis By Market Taxonomy, 2019-2023 9.2. Market Size Value (US$ Mn) & Volume (Unit) Forecast By Market Taxonomy, 2024-2034 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Type 9.2.3. By Application 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Type 9.3.3. By Application 9.4. Key Takeaways 10. Western Europe Market Analysis 2019-2023 and Forecast 2024-2034, By Country 10.1. Historical Market Size Value (US$ Mn) & Volume (Unit) Trend Analysis By Market Taxonomy, 2019-2023 10.2. Market Size Value (US$ Mn) & Volume (Unit) Forecast By Market Taxonomy, 2024-2034 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. U.K. 10.2.1.3. France 10.2.1.4. Spain 10.2.1.5. Italy 10.2.1.6. Rest of Western Europe 10.2.2. By Type 10.2.3. By Application 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Type 10.3.3. By Application 10.4. Key Takeaways 11. Eastern Europe Market Analysis 2019-2023 and Forecast 2024-2034, By Country 11.1. Historical Market Size Value (US$ Mn) & Volume (Unit) Trend Analysis By Market Taxonomy, 2019-2023 11.2. Market Size Value (US$ Mn) & Volume (Unit) Forecast By Market Taxonomy, 2024-2034 11.2.1. By Country 11.2.1.1. Poland 11.2.1.2. Russia 11.2.1.3. Czech Republic 11.2.1.4. Romania 11.2.1.5. Rest of Eastern Europe 11.2.2. By Type 11.2.3. By Application 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Type 11.3.3. By Application 11.4. Key Takeaways 12. South Asia and Pacific Market Analysis 2019-2023 and Forecast 2024-2034, By Country 12.1. Historical Market Size Value (US$ Mn) & Volume (Unit) Trend Analysis By Market Taxonomy, 2019-2023 12.2. Market Size Value (US$ Mn) & Volume (Unit) Forecast By Market Taxonomy, 2024-2034 12.2.1. By Country 12.2.1.1. India 12.2.1.2. Bangladesh 12.2.1.3. Australia 12.2.1.4. New Zealand 12.2.1.5. Rest of South Asia and Pacific 12.2.2. By Type 12.2.3. By Application 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Type 12.3.3. By Application 12.4. Key Takeaways 13. East Asia Market Analysis 2019-2023 and Forecast 2024-2034, By Country 13.1. Historical Market Size Value (US$ Mn) & Volume (Unit) Trend Analysis By Market Taxonomy, 2019-2023 13.2. Market Size Value (US$ Mn) & Volume (Unit) Forecast By Market Taxonomy, 2024-2034 13.2.1. By Country 13.2.1.1. China 13.2.1.2. Japan 13.2.1.3. South Korea 13.2.2. By Type 13.2.3. By Application 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Type 13.3.3. By Application 13.4. Key Takeaways 14. Middle East and Africa Market Analysis 2019-2023 and Forecast 2024-2034, By Country 14.1. Historical Market Size Value (US$ Mn) & Volume (Unit) Trend Analysis By Market Taxonomy, 2019-2023 14.2. Market Size Value (US$ Mn) & Volume (Unit) Forecast By Market Taxonomy, 2024-2034 14.2.1. By Country 14.2.1.1. GCC Countries 14.2.1.2. South Africa 14.2.1.3. Israel 14.2.1.4. Rest of MEA 14.2.2. By Type 14.2.3. By Application 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Type 14.3.3. By Application 14.4. Key Takeaways 15. Key Countries Market Analysis 15.1. U.S. 15.1.1. Pricing Analysis 15.1.2. Market Share Analysis, 2023 15.1.2.1. By Type 15.1.2.2. By Application 15.2. Canada 15.2.1. Pricing Analysis 15.2.2. Market Share Analysis, 2023 15.2.2.1. By Type 15.2.2.2. By Application 15.3. Brazil 15.3.1. Pricing Analysis 15.3.2. Market Share Analysis, 2023 15.3.2.1. By Type 15.3.2.2. By Application 15.4. Mexico 15.4.1. Pricing Analysis 15.4.2. Market Share Analysis, 2023 15.4.2.1. By Type 15.4.2.2. By Application 15.5. Germany 15.5.1. Pricing Analysis 15.5.2. Market Share Analysis, 2023 15.5.2.1. By Type 15.5.2.2. By Application 15.6. U.K. 15.6.1. Pricing Analysis 15.6.2. Market Share Analysis, 2023 15.6.2.1. By Type 15.6.2.2. By Application 15.7. France 15.7.1. Pricing Analysis 15.7.2. Market Share Analysis, 2023 15.7.2.1. By Type 15.7.2.2. By Application 15.8. Spain 15.8.1. Pricing Analysis 15.8.2. Market Share Analysis, 2023 15.8.2.1. By Type 15.8.2.2. By Application 15.9. Italy 15.9.1. Pricing Analysis 15.9.2. Market Share Analysis, 2023 15.9.2.1. By Type 15.9.2.2. By Application 15.10. Poland 15.10.1. Pricing Analysis 15.10.2. Market Share Analysis, 2023 15.10.2.1. By Type 15.10.2.2. By Application 15.11. Russia 15.11.1. Pricing Analysis 15.11.2. Market Share Analysis, 2023 15.11.2.1. By Type 15.11.2.2. By Application 15.12. Czech Republic 15.12.1. Pricing Analysis 15.12.2. Market Share Analysis, 2023 15.12.2.1. By Type 15.12.2.2. By Application 15.13. Romania 15.13.1. Pricing Analysis 15.13.2. Market Share Analysis, 2023 15.13.2.1. By Type 15.13.2.2. By Application 15.14. India 15.14.1. Pricing Analysis 15.14.2. Market Share Analysis, 2023 15.14.2.1. By Type 15.14.2.2. By Application 15.15. Bangladesh 15.15.1. Pricing Analysis 15.15.2. Market Share Analysis, 2023 15.15.2.1. By Type 15.15.2.2. By Application 15.16. Australia 15.16.1. Pricing Analysis 15.16.2. Market Share Analysis, 2023 15.16.2.1. By Type 15.16.2.2. By Application 15.17. New Zealand 15.17.1. Pricing Analysis 15.17.2. Market Share Analysis, 2023 15.17.2.1. By Type 15.17.2.2. By Application 15.18. China 15.18.1. Pricing Analysis 15.18.2. Market Share Analysis, 2023 15.18.2.1. By Type 15.18.2.2. By Application 15.19. Japan 15.19.1. Pricing Analysis 15.19.2. Market Share Analysis, 2023 15.19.2.1. By Type 15.19.2.2. By Application 15.20. South Korea 15.20.1. Pricing Analysis 15.20.2. Market Share Analysis, 2023 15.20.2.1. By Type 15.20.2.2. By Application 15.21. GCC Countries 15.21.1. Pricing Analysis 15.21.2. Market Share Analysis, 2023 15.21.2.1. By Type 15.21.2.2. By Application 15.22. South Africa 15.22.1. Pricing Analysis 15.22.2. Market Share Analysis, 2023 15.22.2.1. By Type 15.22.2.2. By Application 15.23. Israel 15.23.1. Pricing Analysis 15.23.2. Market Share Analysis, 2023 15.23.2.1. By Type 15.23.2.2. By Application 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Type 16.3.3. By Application 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. Becton Dickinson and Company 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segments 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.1.5.2. Product Strategy 17.1.1.5.3. Channel Strategy 17.1.2. Bio-Rad Laboratories Inc 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segments 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.2.5.2. Product Strategy 17.1.2.5.3. Channel Strategy 17.1.3. Thermo Fisher Scientific Inc. 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segments 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.3.5.2. Product Strategy 17.1.3.5.3. Channel Strategy 17.1.4. Merck KGaA 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segments 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.4.5.2. Product Strategy 17.1.4.5.3. Channel Strategy 17.1.5. Agilent Technologies, Inc. 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segments 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.5.5.2. Product Strategy 17.1.5.5.3. Channel Strategy 17.1.6. Qiagen N.V. 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segments 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.6.5.2. Product Strategy 17.1.6.5.3. Channel Strategy 17.1.7. Illumina, Inc. 17.1.7.1. Overview 17.1.7.2. Product Portfolio 17.1.7.3. Profitability by Market Segments 17.1.7.4. Sales Footprint 17.1.7.5. Strategy Overview 17.1.7.5.1. Marketing Strategy 17.1.7.5.2. Product Strategy 17.1.7.5.3. Channel Strategy 17.1.8. DiaSorin S.p.A 17.1.8.1. Overview 17.1.8.2. Product Portfolio 17.1.8.3. Profitability by Market Segments 17.1.8.4. Sales Footprint 17.1.8.5. Strategy Overview 17.1.8.5.1. Marketing Strategy 17.1.8.5.2. Product Strategy 17.1.8.5.3. Channel Strategy 17.1.9. Hologic Inc. 17.1.9.1. Overview 17.1.9.2. Product Portfolio 17.1.9.3. Profitability by Market Segments 17.1.9.4. Sales Footprint 17.1.9.5. Strategy Overview 17.1.9.5.1. Marketing Strategy 17.1.9.5.2. Product Strategy 17.1.9.5.3. Channel Strategy 18. Assumptions & Acronyms Used 19. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Market Value (US$ Mn) Forecast by Region, 2019-2034
Table 2: Global Market Volume (Unit) Forecast by Region, 2019-2034
Table 3: Global Market Value (US$ Mn) Forecast by Type, 2019-2034
Table 4: Global Market Volume (Unit) Forecast by Type, 2019-2034
Table 5: Global Market Value (US$ Mn) Forecast by Application, 2019-2034
Table 6: Global Market Volume (Unit) Forecast by Application, 2019-2034
Table 7: North America Market Value (US$ Mn) Forecast by Country, 2019-2034
Table 8: North America Market Volume (Unit) Forecast by Country, 2019-2034
Table 9: North America Market Value (US$ Mn) Forecast by Type, 2019-2034
Table 10: North America Market Volume (Unit) Forecast by Type, 2019-2034
Table 11: North America Market Value (US$ Mn) Forecast by Application, 2019-2034
Table 12: North America Market Volume (Unit) Forecast by Application, 2019-2034
Table 13: Latin America Market Value (US$ Mn) Forecast by Country, 2019-2034
Table 14: Latin America Market Volume (Unit) Forecast by Country, 2019-2034
Table 15: Latin America Market Value (US$ Mn) Forecast by Type, 2019-2034
Table 16: Latin America Market Volume (Unit) Forecast by Type, 2019-2034
Table 17: Latin America Market Value (US$ Mn) Forecast by Application, 2019-2034
Table 18: Latin America Market Volume (Unit) Forecast by Application, 2019-2034
Table 19: Western Europe Market Value (US$ Mn) Forecast by Country, 2019-2034
Table 20: Western Europe Market Volume (Unit) Forecast by Country, 2019-2034
Table 21: Western Europe Market Value (US$ Mn) Forecast by Type, 2019-2034
Table 22: Western Europe Market Volume (Unit) Forecast by Type, 2019-2034
Table 23: Western Europe Market Value (US$ Mn) Forecast by Application, 2019-2034
Table 24: Western Europe Market Volume (Unit) Forecast by Application, 2019-2034
Table 25: Eastern Europe Market Value (US$ Mn) Forecast by Country, 2019-2034
Table 26: Eastern Europe Market Volume (Unit) Forecast by Country, 2019-2034
Table 27: Eastern Europe Market Value (US$ Mn) Forecast by Type, 2019-2034
Table 28: Eastern Europe Market Volume (Unit) Forecast by Type, 2019-2034
Table 29: Eastern Europe Market Value (US$ Mn) Forecast by Application, 2019-2034
Table 30: Eastern Europe Market Volume (Unit) Forecast by Application, 2019-2034
Table 31: South Asia and Pacific Market Value (US$ Mn) Forecast by Country, 2019-2034
Table 32: South Asia and Pacific Market Volume (Unit) Forecast by Country, 2019-2034
Table 33: South Asia and Pacific Market Value (US$ Mn) Forecast by Type, 2019-2034
Table 34: South Asia and Pacific Market Volume (Unit) Forecast by Type, 2019-2034
Table 35: South Asia and Pacific Market Value (US$ Mn) Forecast by Application, 2019-2034
Table 36: South Asia and Pacific Market Volume (Unit) Forecast by Application, 2019-2034
Table 37: East Asia Market Value (US$ Mn) Forecast by Country, 2019-2034
Table 38: East Asia Market Volume (Unit) Forecast by Country, 2019-2034
Table 39: East Asia Market Value (US$ Mn) Forecast by Type, 2019-2034
Table 40: East Asia Market Volume (Unit) Forecast by Type, 2019-2034
Table 41: East Asia Market Value (US$ Mn) Forecast by Application, 2019-2034
Table 42: East Asia Market Volume (Unit) Forecast by Application, 2019-2034
Table 43: Middle East and Africa Market Value (US$ Mn) Forecast by Country, 2019-2034
Table 44: Middle East and Africa Market Volume (Unit) Forecast by Country, 2019-2034
Table 45: Middle East and Africa Market Value (US$ Mn) Forecast by Type, 2019-2034
Table 46: Middle East and Africa Market Volume (Unit) Forecast by Type, 2019-2034
Table 47: Middle East and Africa Market Value (US$ Mn) Forecast by Application, 2019-2034
Table 48: Middle East and Africa Market Volume (Unit) Forecast by Application, 2019-2034
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Market Value (US$ Mn) by Type, 2024-2034
Figure 2: Global Market Value (US$ Mn) by Application, 2024-2034
Figure 3: Global Market Value (US$ Mn) by Region, 2024-2034
Figure 4: Global Market Value (US$ Mn) Analysis by Region, 2019-2034
Figure 5: Global Market Volume (Unit) Analysis by Region, 2019-2034
Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2024-2034
Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2024-2034
Figure 8: Global Market Value (US$ Mn) Analysis by Type, 2019-2034
Figure 9: Global Market Volume (Unit) Analysis by Type, 2019-2034
Figure 10: Global Market Value Share (%) and BPS Analysis by Type, 2024-2034
Figure 11: Global Market Y-o-Y Growth (%) Projections by Type, 2024-2034
Figure 12: Global Market Value (US$ Mn) Analysis by Application, 2019-2034
Figure 13: Global Market Volume (Unit) Analysis by Application, 2019-2034
Figure 14: Global Market Value Share (%) and BPS Analysis by Application, 2024-2034
Figure 15: Global Market Y-o-Y Growth (%) Projections by Application, 2024-2034
Figure 16: Global Market Attractiveness by Type, 2024-2034
Figure 17: Global Market Attractiveness by Application, 2024-2034
Figure 18: Global Market Attractiveness by Region, 2024-2034
Figure 19: North America Market Value (US$ Mn) by Type, 2024-2034
Figure 20: North America Market Value (US$ Mn) by Application, 2024-2034
Figure 21: North America Market Value (US$ Mn) by Country, 2024-2034
Figure 22: North America Market Value (US$ Mn) Analysis by Country, 2019-2034
Figure 23: North America Market Volume (Unit) Analysis by Country, 2019-2034
Figure 24: North America Market Value Share (%) and BPS Analysis by Country, 2024-2034
Figure 25: North America Market Y-o-Y Growth (%) Projections by Country, 2024-2034
Figure 26: North America Market Value (US$ Mn) Analysis by Type, 2019-2034
Figure 27: North America Market Volume (Unit) Analysis by Type, 2019-2034
Figure 28: North America Market Value Share (%) and BPS Analysis by Type, 2024-2034
Figure 29: North America Market Y-o-Y Growth (%) Projections by Type, 2024-2034
Figure 30: North America Market Value (US$ Mn) Analysis by Application, 2019-2034
Figure 31: North America Market Volume (Unit) Analysis by Application, 2019-2034
Figure 32: North America Market Value Share (%) and BPS Analysis by Application, 2024-2034
Figure 33: North America Market Y-o-Y Growth (%) Projections by Application, 2024-2034
Figure 34: North America Market Attractiveness by Type, 2024-2034
Figure 35: North America Market Attractiveness by Application, 2024-2034
Figure 36: North America Market Attractiveness by Country, 2024-2034
Figure 37: Latin America Market Value (US$ Mn) by Type, 2024-2034
Figure 38: Latin America Market Value (US$ Mn) by Application, 2024-2034
Figure 39: Latin America Market Value (US$ Mn) by Country, 2024-2034
Figure 40: Latin America Market Value (US$ Mn) Analysis by Country, 2019-2034
Figure 41: Latin America Market Volume (Unit) Analysis by Country, 2019-2034
Figure 42: Latin America Market Value Share (%) and BPS Analysis by Country, 2024-2034
Figure 43: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024-2034
Figure 44: Latin America Market Value (US$ Mn) Analysis by Type, 2019-2034
Figure 45: Latin America Market Volume (Unit) Analysis by Type, 2019-2034
Figure 46: Latin America Market Value Share (%) and BPS Analysis by Type, 2024-2034
Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Type, 2024-2034
Figure 48: Latin America Market Value (US$ Mn) Analysis by Application, 2019-2034
Figure 49: Latin America Market Volume (Unit) Analysis by Application, 2019-2034
Figure 50: Latin America Market Value Share (%) and BPS Analysis by Application, 2024-2034
Figure 51: Latin America Market Y-o-Y Growth (%) Projections by Application, 2024-2034
Figure 52: Latin America Market Attractiveness by Type, 2024-2034
Figure 53: Latin America Market Attractiveness by Application, 2024-2034
Figure 54: Latin America Market Attractiveness by Country, 2024-2034
Figure 55: Western Europe Market Value (US$ Mn) by Type, 2024-2034
Figure 56: Western Europe Market Value (US$ Mn) by Application, 2024-2034
Figure 57: Western Europe Market Value (US$ Mn) by Country, 2024-2034
Figure 58: Western Europe Market Value (US$ Mn) Analysis by Country, 2019-2034
Figure 59: Western Europe Market Volume (Unit) Analysis by Country, 2019-2034
Figure 60: Western Europe Market Value Share (%) and BPS Analysis by Country, 2024-2034
Figure 61: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024-2034
Figure 62: Western Europe Market Value (US$ Mn) Analysis by Type, 2019-2034
Figure 63: Western Europe Market Volume (Unit) Analysis by Type, 2019-2034
Figure 64: Western Europe Market Value Share (%) and BPS Analysis by Type, 2024-2034
Figure 65: Western Europe Market Y-o-Y Growth (%) Projections by Type, 2024-2034
Figure 66: Western Europe Market Value (US$ Mn) Analysis by Application, 2019-2034
Figure 67: Western Europe Market Volume (Unit) Analysis by Application, 2019-2034
Figure 68: Western Europe Market Value Share (%) and BPS Analysis by Application, 2024-2034
Figure 69: Western Europe Market Y-o-Y Growth (%) Projections by Application, 2024-2034
Figure 70: Western Europe Market Attractiveness by Type, 2024-2034
Figure 71: Western Europe Market Attractiveness by Application, 2024-2034
Figure 72: Western Europe Market Attractiveness by Country, 2024-2034
Figure 73: Eastern Europe Market Value (US$ Mn) by Type, 2024-2034
Figure 74: Eastern Europe Market Value (US$ Mn) by Application, 2024-2034
Figure 75: Eastern Europe Market Value (US$ Mn) by Country, 2024-2034
Figure 76: Eastern Europe Market Value (US$ Mn) Analysis by Country, 2019-2034
Figure 77: Eastern Europe Market Volume (Unit) Analysis by Country, 2019-2034
Figure 78: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2024-2034
Figure 79: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024-2034
Figure 80: Eastern Europe Market Value (US$ Mn) Analysis by Type, 2019-2034
Figure 81: Eastern Europe Market Volume (Unit) Analysis by Type, 2019-2034
Figure 82: Eastern Europe Market Value Share (%) and BPS Analysis by Type, 2024-2034
Figure 83: Eastern Europe Market Y-o-Y Growth (%) Projections by Type, 2024-2034
Figure 84: Eastern Europe Market Value (US$ Mn) Analysis by Application, 2019-2034
Figure 85: Eastern Europe Market Volume (Unit) Analysis by Application, 2019-2034
Figure 86: Eastern Europe Market Value Share (%) and BPS Analysis by Application, 2024-2034
Figure 87: Eastern Europe Market Y-o-Y Growth (%) Projections by Application, 2024-2034
Figure 88: Eastern Europe Market Attractiveness by Type, 2024-2034
Figure 89: Eastern Europe Market Attractiveness by Application, 2024-2034
Figure 90: Eastern Europe Market Attractiveness by Country, 2024-2034
Figure 91: South Asia and Pacific Market Value (US$ Mn) by Type, 2024-2034
Figure 92: South Asia and Pacific Market Value (US$ Mn) by Application, 2024-2034
Figure 93: South Asia and Pacific Market Value (US$ Mn) by Country, 2024-2034
Figure 94: South Asia and Pacific Market Value (US$ Mn) Analysis by Country, 2019-2034
Figure 95: South Asia and Pacific Market Volume (Unit) Analysis by Country, 2019-2034
Figure 96: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2024-2034
Figure 97: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2024-2034
Figure 98: South Asia and Pacific Market Value (US$ Mn) Analysis by Type, 2019-2034
Figure 99: South Asia and Pacific Market Volume (Unit) Analysis by Type, 2019-2034
Figure 100: South Asia and Pacific Market Value Share (%) and BPS Analysis by Type, 2024-2034
Figure 101: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Type, 2024-2034
Figure 102: South Asia and Pacific Market Value (US$ Mn) Analysis by Application, 2019-2034
Figure 103: South Asia and Pacific Market Volume (Unit) Analysis by Application, 2019-2034
Figure 104: South Asia and Pacific Market Value Share (%) and BPS Analysis by Application, 2024-2034
Figure 105: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Application, 2024-2034
Figure 106: South Asia and Pacific Market Attractiveness by Type, 2024-2034
Figure 107: South Asia and Pacific Market Attractiveness by Application, 2024-2034
Figure 108: South Asia and Pacific Market Attractiveness by Country, 2024-2034
Figure 109: East Asia Market Value (US$ Mn) by Type, 2024-2034
Figure 110: East Asia Market Value (US$ Mn) by Application, 2024-2034
Figure 111: East Asia Market Value (US$ Mn) by Country, 2024-2034
Figure 112: East Asia Market Value (US$ Mn) Analysis by Country, 2019-2034
Figure 113: East Asia Market Volume (Unit) Analysis by Country, 2019-2034
Figure 114: East Asia Market Value Share (%) and BPS Analysis by Country, 2024-2034
Figure 115: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024-2034
Figure 116: East Asia Market Value (US$ Mn) Analysis by Type, 2019-2034
Figure 117: East Asia Market Volume (Unit) Analysis by Type, 2019-2034
Figure 118: East Asia Market Value Share (%) and BPS Analysis by Type, 2024-2034
Figure 119: East Asia Market Y-o-Y Growth (%) Projections by Type, 2024-2034
Figure 120: East Asia Market Value (US$ Mn) Analysis by Application, 2019-2034
Figure 121: East Asia Market Volume (Unit) Analysis by Application, 2019-2034
Figure 122: East Asia Market Value Share (%) and BPS Analysis by Application, 2024-2034
Figure 123: East Asia Market Y-o-Y Growth (%) Projections by Application, 2024-2034
Figure 124: East Asia Market Attractiveness by Type, 2024-2034
Figure 125: East Asia Market Attractiveness by Application, 2024-2034
Figure 126: East Asia Market Attractiveness by Country, 2024-2034
Figure 127: Middle East and Africa Market Value (US$ Mn) by Type, 2024-2034
Figure 128: Middle East and Africa Market Value (US$ Mn) by Application, 2024-2034
Figure 129: Middle East and Africa Market Value (US$ Mn) by Country, 2024-2034
Figure 130: Middle East and Africa Market Value (US$ Mn) Analysis by Country, 2019-2034
Figure 131: Middle East and Africa Market Volume (Unit) Analysis by Country, 2019-2034
Figure 132: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2024-2034
Figure 133: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2024-2034
Figure 134: Middle East and Africa Market Value (US$ Mn) Analysis by Type, 2019-2034
Figure 135: Middle East and Africa Market Volume (Unit) Analysis by Type, 2019-2034
Figure 136: Middle East and Africa Market Value Share (%) and BPS Analysis by Type, 2024-2034
Figure 137: Middle East and Africa Market Y-o-Y Growth (%) Projections by Type, 2024-2034
Figure 138: Middle East and Africa Market Value (US$ Mn) Analysis by Application, 2019-2034
Figure 139: Middle East and Africa Market Volume (Unit) Analysis by Application, 2019-2034
Figure 140: Middle East and Africa Market Value Share (%) and BPS Analysis by Application, 2024-2034
Figure 141: Middle East and Africa Market Y-o-Y Growth (%) Projections by Application, 2024-2034
Figure 142: Middle East and Africa Market Attractiveness by Type, 2024-2034
Figure 143: Middle East and Africa Market Attractiveness by Application, 2024-2034
Figure 144: Middle East and Africa Market Attractiveness by Country, 2024-2034
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What Was the Value of the Molecular Diagnostics Reagent Market in 2019?
The global molecular diagnostics reagent market size was worth US$ 507.1 million in 2019.
What is the Sales Outlook for the Molecular Diagnostics Reagent Market in 2024?
The sales of molecular diagnostics reagents are likely to be valued at US$ 10,584.3 million in 2024.
What is the Expected Size of the Market by 2034?
The demand for molecular diagnostics reagents is projected to reach a market value of US$ 20,009.6 million by 2034.
What is the Growth Projection for the Market?
The adoption of molecular diagnostics reagents is projected to rise at a CAGR of 6.6% between 2024 and 2034.
At What CAGR is the Market in North America Predicted to Grow?
The North America market is forecasted to expand at a CAGR of 4.8% from 2024 to 2034.
At What CAGR is the Market in East Asia Predicted to Grow?
The East Asia market is forecasted to expand at a CAGR of 6.4% through 2034.
Molecular Diagnostics Reagent Market